Arkolith/Funds/General Atlantic, L.P.

General Atlantic, L.P.

CIK 1017645Hedge fund
Holdings as of Jun 30, 2026·disclosed Aug 14, 2026·~45-day 13F lag·13F-HR
Active Filer

General Atlantic, L.P. holds a concentrated book of 12 stocks worth $2.9B as of Q2 2026 (disclosed Aug 14, 2026, a ~45-day 13F lag). This quarter they opened Liftoff Mobile and trimmed Pharvaris NV. Their largest long position is Liftoff Mobile at 21% of the equity book.

Opened
4
bought for the first time
  • Liftoff Mobile
  • Seaport Therapeutics
  • Parabilis Medicines
  • +1 more · largest first
Added to
1
already held, bought more

Concentration

Top-heavy: concentrated book

Top 5 holdings
80%
Top 10 holdings
99%
Top 20 holdings
100%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Direct sector allocation

73% mapped to company sectors

ETF / fund or unclassified
27%
Financials
26%
Industrials
22%
Health Care
13%
Information Technology
12%
Consumer Discretionary
0%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices, no cost basis

Bought
  • LIFTOFF MOBILE
    New$608.1M
  • SEAPORT THERAPEUTICS
    New$132.5M
  • +26%$73.2M
  • PARABILIS MEDICINES
    New$42.1M
Trimmed / exited

Funds with the most overlap

Other tracked managers holding the same core names as General Atlantic, L.P.

Manager / fundShared namesTheir $ in those
GEODE CAPITAL MANAGEMENT, LLC14 / 12$1.2B
BlackRock, Inc.13 / 12$2.6B
UBS Group AG13 / 12$630.1M
MORGAN STANLEY13 / 12$532.6M
GOLDMAN SACHS GROUP INC13 / 12$386.0M
Ken Griffin13 / 12$315.9M
SUSQUEHANNA INTERNATIONAL GROUP, LLP13 / 12$194.7M
BANK OF AMERICA CORP /DE/12 / 12$383.9M

Ranked by how many of General Atlantic, L.P.'s top 12 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

12 positions
#SecurityValueShares% PortLast moveHistory
1Liftoff Mobile
COM
$608.1M25.32M
20.9%
New
New position
2Dlocal
CL A
$606.3M46.66M
20.9%
Held
3CHIME
COM SHS CL A
$435.4M21.26M
15.0%
Held
4Alkami
COM
$351.1M19.38M
12.1%
+26%
Added · +4.0M sh
5XP, Inc
CL A
$334.4M20.57M
11.5%
Held
6Pharvaris
COM
$226.5M6.55M
7.8%
−18%
Reduced · −1.5M sh
7Seaport Therapeutics
COM
$132.5M6.10M
4.6%
New
New position
8Nurix Therapeutics
COM
$73.6M3.03M
2.5%
−26%
Reduced · −1.1M sh
9Revolution Medicines
COM
$67.0M357.8K
2.3%
−49%
Reduced · −350K sh
10Parabilis Medicines
COM
$42.1M1.54M
1.4%
New
New position
11Riskified
CL A
$26.8M5.32M
0.9%
Held
12Grove Collaborative
CL A
$3.1M2.47M
0.1%
Held
Showing all 12 positions
Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Build

Ask your agent what General Atlantic, L.P. owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1017645/holdings"
Ask your agent
Use Arkolith to show GENERAL ATLANTIC, L.P.'s latest
holdings, largest changes, and filing provenance.

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q2 2026Jun 30, 2026Aug 14, 202612$2.9B13F-HR
Q1 2026Mar 31, 2026May 15, 202612$2.1B13F-HR
Q4 2025Dec 31, 2025Feb 17, 202613$2.9B13F-HR
Q3 2025Sep 30, 2025Nov 13, 202516$3.3B13F-HR
Q2 2025Jun 30, 2025Aug 14, 202515$3.6B13F-HR
Q1 2025Mar 31, 2025May 14, 202515$3.0B13F-HR
Q4 2024Dec 31, 2024Feb 7, 202516$2.8B13F-HR
Q3 2024Sep 30, 2024Nov 12, 202418$3.5B13F-HR
Q2 2024Jun 30, 2024Aug 14, 202419$3.2B13F-HR
Q1 2024Mar 31, 2024May 15, 202422$4.3B13F-HR
Q4 2023Dec 31, 2023Feb 13, 202426$7.0B13F-HR
Q3 2023Sep 30, 2023Nov 14, 202329$6.5B13F-HR
Q2 2023Jun 30, 2023Aug 11, 202330$6.3B13F-HR
Q1 2023Mar 31, 2023May 15, 202331$8.6B13F-HR
Q4 2022Dec 31, 2022Feb 14, 202333$7.6B13F-HR
Q3 2022Sep 30, 2022Nov 14, 202239$8.5B13F-HR
Q2 2022Jun 30, 2022Aug 12, 202238$7.7B13F-HR
Q1 2022Mar 31, 2022May 16, 202235$10.9B13F-HR
Q4 2021Dec 31, 2021Feb 11, 202232$13.0B13F-HR
Q3 2021Sep 30, 2021Nov 15, 202125$17.1B13F-HR
Q2 2021Jun 30, 2021Aug 13, 202117$14.1B13F-HR
Q1 2021Mar 31, 2021May 17, 202112$8.5B13F-HR
Q4 2020Dec 31, 2020Feb 12, 20219$7.7B13F-HR
Q3 2020Sep 30, 2020Nov 13, 20207$6.5B13F-HR

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.